Cargando…
Reperfusion Therapy with Rapamycin Attenuates Myocardial Infarction through Activation of AKT and ERK
Prompt coronary reperfusion is the gold standard for minimizing injury following acute myocardial infarction. Rapamycin, mammalian target of Rapamycin (mTOR) inhibitor, exerts preconditioning-like cardioprotective effects against ischemia/reperfusion (I/R) injury. We hypothesized that Rapamycin, giv...
Autores principales: | Filippone, Scott M., Samidurai, Arun, Roh, Sean K., Cain, Chad K., He, Jun, Salloum, Fadi N., Kukreja, Rakesh C., Das, Anindita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360974/ https://www.ncbi.nlm.nih.gov/pubmed/28373901 http://dx.doi.org/10.1155/2017/4619720 |
Ejemplares similares
-
Preclinical model of type 1 diabetes and myocardial ischemia/reperfusion injury in conscious rabbits—demonstration of cardioprotection with rapamycin
por: Samidurai, Arun, et al.
Publicado: (2021) -
Differential Regulation of mTOR Complexes with miR-302a Attenuates Myocardial Reperfusion Injury in Diabetes
por: Samidurai, Arun, et al.
Publicado: (2020) -
Single-Dose Treatment with Rapamycin Preserves Post-Ischemic Cardiac Function through Attenuation of Fibrosis and Inflammation in Diabetic Rabbit
por: Samidurai, Arun, et al.
Publicado: (2023) -
Deciphering Non-coding RNAs in Cardiovascular Health and Disease
por: Das, Anindita, et al.
Publicado: (2018) -
Emerging Role of mTOR Signaling-Related miRNAs in Cardiovascular Diseases
por: Samidurai, Arun, et al.
Publicado: (2018)